Daptomycin Activity Tested Against Gram-positive Bacteria Isolated from Medical Centers Located in China (2006)

被引:0
|
作者
Chen, M. [1 ]
Wang, H. [1 ]
Turnidge, J. [2 ]
Jones, R. [3 ]
Sader, H. [3 ]
机构
[1] Beijing Union Med Coll Hosp, Beijing, Peoples R China
[2] Womens & Childrens Hosp, Adelaide, SA, Australia
[3] JMI Labs, N Liberty, IA USA
关键词
D O I
10.1016/j.ijid.2008.05.722
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:E268 / E268
页数:1
相关论文
共 50 条
  • [21] Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018–2020)
    Helio S. Sader
    Mariana Castanheira
    Michael D. Huband
    Dee Shortridge
    Cecilia G. Carvalhaes
    Rodrigo M. Mendes
    European Journal of Clinical Microbiology & Infectious Diseases, 2022, 41 : 867 - 873
  • [22] Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres
    Gales, AC
    Sader, HS
    Jones, RN
    CLINICAL MICROBIOLOGY AND INFECTION, 2005, 11 (02) : 95 - 100
  • [23] Antimicrobial Activity of Daptomycin and Comparator Agents Tested Against Gram-positive Organisms from Hong Kong, Indonesia, Philippines, Singapore and Thailand
    Turnidge, J.
    Bell, J.
    Jones, R.
    Sader, H.
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2008, 12 : E267 - E268
  • [24] CoO Thin Nanosheets Exhibit Higher Antimicrobial Activity Against Tested Gram-positive Bacteria Than Gram-negative Bacteria
    Khan, Shams Tabrez
    Wahab, Rizwan
    Ahmad, Javed
    Al-Khedhairy, Abdulaziz A.
    Siddiqui, Maqsood A.
    Saquib, Quaiser
    Ali, Bahy A.
    Musarrat, Javed
    KOREAN CHEMICAL ENGINEERING RESEARCH, 2015, 53 (05): : 565 - 569
  • [25] Antimicrobial activity of dalbavancin against Gram-positive bacteria isolated from patients hospitalized with bloodstream infection in United States and European medical centers (2018-2020)
    Sader, Helio S.
    Castanheira, Mariana
    Huband, Michael D.
    Shortridge, Dee
    Carvalhaes, Cecilia G.
    Mendes, Rodrigo M.
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (05) : 867 - 873
  • [26] The in vitro activity of daptomycin against 514 Gram-positive aerobic clinical isolates
    King, A
    Phillips, I
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (02) : 219 - 223
  • [27] Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004)
    Sader, H. S.
    Streit, J. M.
    Fritsche, T. R.
    Jones, R. N.
    CLINICAL MICROBIOLOGY AND INFECTION, 2006, 12 (09) : 844 - 852
  • [28] The spectrum of Gram-positive bloodstream infections in patients with hematologic malignancies, and the in vitro activity of various quinolones against Gram-positive bacteria isolated from cancer patients
    Rolston, KVI
    Yadegarynia, D
    Kontoyiannis, DP
    Raad, II
    Ho, DH
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2006, 10 (03) : 223 - 230
  • [29] Platinum Cyclooctadiene Complexes with Activity against Gram-positive Bacteria
    Frei, Angelo
    Ramu, Soumya
    Lowe, Gabrielle J.
    Dinh, Hue
    Semenec, Lucie
    Elliott, Alysha G.
    Zuegg, Johannes
    Deckers, Anke
    Jung, Nicole
    Brase, Stefan
    Cain, Amy K.
    Blaskovich, Mark A. T.
    CHEMMEDCHEM, 2021, 16 (20) : 3165 - 3171
  • [30] Activity of newer fluoroquinolones in vitro against gram-positive bacteria
    Eliopoulos, GM
    DRUGS, 1999, 58 (Suppl 2) : 23 - 28